However, Luteolin sensitizes the anticancer effect of cisplatin by supporting the c-Jun NH2-terminal kinase-mediated p53 phosphorylation and stabilization [66], which underscores the importance of understanding cancer-related mutations within p53 phosphorylation site motifs. Here, TP53 is linked to cancer.